Congenital amegakaryocytic thrombocytopenia: genes and variants

Explore variant evidence for Congenital amegakaryocytic thrombocytopenia across 1 analyzed protein (MPL). Linked ClinVar records include 19 pathogenic or likely pathogenic variants, 149 variants of uncertain significance and 17 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-10-15. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Congenital amegakaryocytic thrombocytopenia

ClinVar pathogenic and likely pathogenic variants linked to Congenital amegakaryocytic thrombocytopenia

VariantPositionProtein partClinical label
MPL P136L136ExtracellularPathogenic / likely pathogenic (★★)
MPL P136H136ExtracellularPathogenic / likely pathogenic (★★)
MPL P136R136ExtracellularPathogenic / likely pathogenic (★★)
MPL R257C257Fibronectin type-III 1Pathogenic / likely pathogenic (★★)
MPL F104S104ExtracellularPathogenic / likely pathogenic (★★)
MPL W435C435Fibronectin type-III 2Pathogenic / likely pathogenic (★★)
MPL R102P102ExtracellularPathogenic / likely pathogenic (★★)
MPL R102C102ExtracellularPathogenic / likely pathogenic (★★)
MPL W154R154ExtracellularPathogenic / likely pathogenic (★★)
MPL S505N505TransmembranePathogenic / likely pathogenic (★★)
MPL P635L635CytoplasmicPathogenic / likely pathogenic (★★)
MPL P106L106ExtracellularPathogenic / likely pathogenic (★★)
MPL R257L257Fibronectin type-III 1Pathogenic / likely pathogenic (★)
MPL R102H102ExtracellularPathogenic / likely pathogenic (★)
MPL L254P254Fibronectin type-III 1Pathogenic / likely pathogenic (★)
MPL W435R435Fibronectin type-III 2Pathogenic / likely pathogenic (★)
MPL R426P426Fibronectin type-III 2Pathogenic / likely pathogenic (★)
MPL Y69H69ExtracellularPathogenic / likely pathogenic (★)
MPL G131R131ExtracellularPathogenic / likely pathogenic (★)

Uncertain variants prioritized for review in Congenital amegakaryocytic thrombocytopenia

VariantPositionProtein partClinical labelEvidence
MPL R257H257Fibronectin type-III 1Uncertain (★)+6: 3 other pathogenic changes within 3 positions; R257C at the same position is pathogenic; REVEL 0.811

Which prediction tools work for Congenital amegakaryocytic thrombocytopenia

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Diseases related to Congenital amegakaryocytic thrombocytopenia

Frequently asked questions

Which genes have records linked to Congenital amegakaryocytic thrombocytopenia?

This view contains 1 analyzed proteins: MPL. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 19 pathogenic or likely pathogenic variants, 149 variants of uncertain significance and 17 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 243 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center